In a process for thermally desorbing a phase material (20), in particular for conditioning a fiber for carrying out a solid-phase microextraction, the phase material (20) is heated along a temperature curve. The temperature curve of the phase material (20) during desorption includes at least one low point.

A composite material of polyurethane foam having a layer of reduced graphene oxide and polystyrene is described. This composite material may be made by contacting a polyurethane foam with a suspension of reduced graphene oxide, drying, and then irradiating in the presence of styrene vapor. The composite material has a hydrophobic surface that may be exploited for separating a nonpolar phase, such as oil, from an aqueous solution.

The present disclosure relates to an alkylated graphene oxide membrane comprising a plurality of graphene oxide layers, each graphene oxide layer including at least one graphene oxide sheet covalently coupled to a chemical spacer, the chemical spacer being of Formula I:

##STR00001##

The present disclosure also relates to a filtration apparatus comprising an alkylated graphene oxide membrane disposed on a support substrate.

An absorbent belt according to an embodiment is for absorbing an oil contained in a cleaning liquid, and the absorbent belt includes a sponge member coated with dopamine (DA) formed by immersing a sponge in a solution mixed with the dopamine in a preset range of 1 g/L or more and 16 g/L or less.

Fibrous mats composed of polymeric fibers comprising an aromatic polymer are provided. Further, articles and methods of use of the fibrous mats, including, but not limited to filters and membranes for sampling of fluid samples, are also provided.

An adsorbent bed, including at least one elementary composite structure that includes adsorbent particles in a polymer matrix, wherein the adsorbent bed has a bed packing, ρ.sub.bed, defined as a volume occupied by the at least one elementary composite structure V.sub.ecs divided by a volume of the adsorbent bed V.sub.bed where ρ.sub.bed is greater than 0.60.

A dissolved air floatation apparatus including an ultrafine bubble-containing liquid production device and a dissolved air floatation tank. The ultrafine bubble-containing liquid production device includes a gas-liquid mixing unit and a bubble-containing liquid separation device. The bubble-containing liquid separation device swirls a liquid containing ultrafine bubbles and larger bubbles in a storage tank to concentrate the liquid that contains the ultrafine bubbles and the liquid that contains the larger bubbles to a central part of the swirling flow followed by discharge. A pressurized ultrafine bubble-containing liquid is mixed in a raw liquid containing a subject to be cleansed and is poured into the dissolved air floatation tank to cause a suspended substance and a dissolved component in the raw liquid to be adsorbed on an interface of fine bubbles and be floated in the dissolved air floatation tank to be extracted.

The present invention relates to an absorbent material, the absorbent material comprising: a matrix formed from a fibrous material and one or more polymerised binder reagents. The present invention further relates to a method for producing an absorbent material, the method comprising the steps of: combining a feedstock comprising fibrous material with one or more binder reagents; and introducing the feedstock into an agglomeration apparatus in the presence of a polymerisation activator to produce the absorbent material.

The present invention provides a mixture of adsorbents which has the capacity to adsorb high concentrations of antibiotics from a diverse range of classes, pathogens, and heavy metals. The invention is a mixture of various charcoal adsorbents including areca nut, bamboo, pine nut, coconut shell and paper that can deplete a wide variety of antibiotics in one go.

Methods for quantifying an amount of exosomes in subject derived biological fluid and comparing to a control provides for a method of identifying a medical condition. Removing an amount of the exosomes by adsorption and binding of the exosomes to an absorbent material, and administering the reconstituted biological fluid comprising a reduced amount of exosomes back to the subject also provides for a method of treating the identified medical condition.